OMRON Healthcare Co., Ltd.
Department of Public Health, Shiga University of Medical Science.
J Epidemiol. 2018 Jan 5;28(1):41-47. doi: 10.2188/jea.JE20160144. Epub 2017 Oct 25.
Reducing the urinary sodium-to-potassium ratio is important for reducing both blood pressure and risk of cardiovascular disease. Among free-living Japanese individuals, we carried out a randomized trial to clarify the effect of lifestyle modification for lowering urinary sodium-to-potassium ratio using a self-monitoring device.
This was an open, prospective, parallel randomized, controlled trial. Ninety-two individuals were recruited from Japanese volunteers. Participants were randomly allocated into intervention and control groups. A month-long dietary intervention on self-monitoring urinary sodium-to-potassium ratio was carried out using monitors (HEU-001F, OMRON Healthcare Co., Ltd., Kyoto, Japan). All participants had brief dietary education and received a leaflet as usual care. Monitors were handed out to the intervention group, but not to the control group. The intervention group was asked to measure at least one spot urine sodium-to-potassium ratio daily, and advised to lower their sodium-to-potassium ratio toward the target of less than 1. Outcomes included changes in 24-hour urinary sodium-to-potassium ratio, sodium excretion, potassium excretion, blood pressure, and body weight in both groups.
Mean measurement frequency of monitoring was 2.8 times/day during the intervention. Changes in urinary sodium-to-potassium ratio were -0.55 in the intervention group and -0.06 in the control group (P = 0.088); respective sodium excretion changes were -18.5 mmol/24 hours and -8.7 mmol/24 hours (P = 0.528); and corresponding potassium excretion was 2.6 mmol/24 hours and -1.5 mmol/24 hours (P = 0.300). No significant reductions were observed in either blood pressure or body weight after the intervention.
Providing the device to self-monitor a sodium-to-potassium ratio did not achieve the targeted reduction of the ratio in "pure self-management" settings, indicating further needs to study an effective method to enhance the synergetic effect of dietary programs and self-monitoring practice to achieve the reduction. However, we cannot deny the possibility of reducing sodium-to-potassium ratio using a self-monitoring device.
降低尿钠/钾比值对于降低血压和降低心血管疾病风险非常重要。在自由生活的日本个体中,我们使用自我监测设备进行了一项随机试验,以明确通过生活方式改变来降低尿钠/钾比值的效果。
这是一项开放、前瞻性、平行随机对照试验。从日本志愿者中招募了 92 名参与者。参与者被随机分配到干预组和对照组。使用监测器(欧姆龙健康医疗有限公司的 HEU-001F)进行为期一个月的自我监测尿钠/钾比值的饮食干预。所有参与者都接受了简短的饮食教育,并获得了常规护理的传单。监测器分发给干预组,但不给对照组。要求干预组每天至少测量一次尿钠/钾比值,并建议将其钠/钾比值降低到低于 1 的目标值。结果包括两组 24 小时尿钠/钾比值、钠排泄量、钾排泄量、血压和体重的变化。
干预期间监测的平均测量频率为每天 2.8 次。干预组尿钠/钾比值变化为-0.55,对照组为-0.06(P=0.088);相应的钠排泄量变化分别为-18.5mmol/24 小时和-8.7mmol/24 小时(P=0.528);相应的钾排泄量分别为 2.6mmol/24 小时和-1.5mmol/24 小时(P=0.300)。干预后,血压或体重均未显著降低。
在“纯自我管理”环境中,提供自我监测钠/钾比值的设备并未实现比值的目标降低,这表明需要进一步研究有效方法来增强饮食计划和自我监测实践的协同作用,以实现比值的降低。然而,我们不能否认使用自我监测设备降低钠/钾比值的可能性。